NCT05775653

Brief Summary

Background: The number of people living with chronic conditions limiting the ability to perform activities of daily living (ADL) tasks is increasing. Occupational therapists are trained to deliver interventions to improve ADL ability. Municipality occupational therapy interventions are usually delivered as one-to-one sessions in the client´s home. While this intervention format might be effective, a group-based intervention format might be as effective but more cost-effective? Hence, the group-based ADAPT program was developed, piloted and evaluated for its functioning and feasibility in municipality settings. These studies provided initial evidence for the ADAPT Programs effectiveness. A randomized controlled trial (RCT) is however needed to document effectiveness, processes, and cost-effectiveness of the ADAPT program versus usual occupational therapy (UOT) for people with chronic conditions. Prior to the RCT, this pilot and feasibility study will be conducted to test aspects of trial design, conduct and processes as well as intervention content and delivery. Material and Methods: A total of 16 home dwelling persons with chronic conditions, experiencing ADL task performance problems will be randomized and allocated to receive ADAPT (intervention) or UOT (control). Effectiveness and cost-effectiveness assessments are collected at baseline and post intervention i.e., 3-months (week 12) and 6-months (week 26) from baseline. Pilot and feasibility aspects will be evaluated by means of registrations forms filled out by the OTs delivering ADAPT and people with chronic conditions attending ADAPT. Registrations are designed to inform aspects of 1) recruitment and retention, 2) trial participation, 3) impact of trial on participants and staff, 4) completion rates, 5) fidelity and dose 6) assesable information and 7) adaptation of trial conduct to local context. Progression criteria for when to 'go', 'amend' or 'be alert/stop' are defined, to support the decision on whether to continue to RCT or the need to adjust design or procedures,

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2023

Completed
25 days until next milestone

First Posted

Study publicly available on registry

March 20, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

March 27, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 9, 2023

Completed
Last Updated

May 6, 2024

Status Verified

November 1, 2023

Enrollment Period

4 months

First QC Date

February 23, 2023

Last Update Submit

May 2, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in observed motor ability

    Assessment of Motor and Process Skills (AMPS) is a unidimensional linear measure in which higher scores are better outcome

    week 12

Secondary Outcomes (11)

  • Change in self-reported ability to perform activities of daily living tasks

    week 12 and 26

  • Change in observed motor ability

    week 26

  • Change in observed process ability

    week 12 and 26

  • Change in self-reported satisfaction with ability to perform activities of daily living tasks-

    week 12 and 26

  • Perceived change in ability to perform activities of daily living tasks

    week 12 and 26

  • +6 more secondary outcomes

Other Outcomes (1)

  • Perceived mental well-being

    week 12 and 24

Study Arms (2)

ADAPT program

EXPERIMENTAL

The ADAPT program is a structured and individualized group-based program.

Other: ADAPT program

Usual Occupational Therapy (UOT)

ACTIVE COMPARATOR

UOT is delivered by one occupational therapist. .

Other: UOT

Interventions

The ADAPT program is a structured and individualized group-based program, in which two occupational therapists teach groups of people the skills of problem-solving more efficiently as means to overcome ADL task performance problems. The ADAPT program 3.0 includes 10 two-hour sessions and is followed by two booster sessions to support sustainable gains.

ADAPT program
UOTOTHER

UOT is delivered by one occupational therapist. Sessions are individualised and focus on improving ADL ability e.g. by practicing the performance of ADL task. UOT typiccally includes 7 one-to-one sessions of 60 minutes, delivered over a 10-week period in the clients´ homes. The dose is however not fixed but based on the occupational therapists´ clinical judgement.

Usual Occupational Therapy (UOT)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 18 years of age
  • ≥ one year since medical diagnosed with one or more chronic conditions
  • Lives in own home
  • Experience ADL task performance problems
  • Show ADL motor ability measures \<1.50 on the AMPS ADL motor skills scale (indicate increased effort during ADL task performance)
  • Communicate independently and relevantly orally and in writing (without severe cognitive deficits, aphasia, significant hearing loss or dyslexia)
  • Willing and interested in attending occupational therapy interventions focused on improving ADL task performance.

You may not qualify if:

  • ADL process ability measures \<0.00 indicating that the person is unlikely to profit from educational programs focused on using adaptational strategies
  • Mental illness and/or other acute (\<3 months) conditions effecting ADL task performance
  • Language barriers
  • Known substance abuse

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Parker Research Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg Frederiksberg, Denmark

Frederiksberg, 2000, Denmark

Location

MeSH Terms

Conditions

Chronic DiseaseMultiple Chronic Conditions

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Cecilie von Bülow, PhD

    Parker Institute, Bispebjerg and Frederiksberg Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The trial attempts to blind clients and assessors. Clients are informed that they will be allocated to one of two occupational therapy intervention programs that both aims to improve ADL ability, but overall primarily differ in the format i.e. a group-based versus a one-to-one intervention program. Clients are however not informed, which of the two types of formats that are the new experimental intervention format (ADAPT). Baseline assessments are conducted prior to randomization by the local project coordinator and the project coordinator is instructed not to reveal which intervention that is the new experimental intervention. The post- and follow-up assessor, an externally recruited occupationa therapist from a nearby hospital research unit, is also instructed not to disclose which intervention that is the new. Finally, all clients are reminded not to disclose any details, that may provide the outcome assessor with insight regarding their group allocation.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: A randomized controlled pilot and feasibility study
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

February 23, 2023

First Posted

March 20, 2023

Study Start

March 27, 2023

Primary Completion

July 31, 2023

Study Completion

November 9, 2023

Last Updated

May 6, 2024

Record last verified: 2023-11

Data Sharing

IPD Sharing
Will not share

Locations